A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes ...

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

(WASHINGTON) — The U.S. Food and Drug Administration approved a first-of-its-kind insulin device today designed to automatically deliver insulin for type 1 diabetics. The device has many in the ...

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

The insulin delivery device market is primarily propelled by the growing incidence of diabetes, a shift toward home-based diabetes care, heightened awareness and patient education, advancements in ...

Cambridge, UK, 25 September 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, has signed ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

Today, most people who take insulin to manage diabetes inject the insulin with a needle and syringe that delivers insulin just under the skin. Several other devices for taking insulin are available, ...

Thousands of diabetic patients are hacking into their insulin pumps to make them automatically estimate blood glucose levels and adjust insulin levels accordingly, Irl Hirsch, MD, a professor at ...

DexCom › One way to earn above-average market returns -- which isn't always easy -- is to invest in companies that have lagged the market but are likely to recover over the long run. As the basic ...

A Global Business Intelligence Research report estimates the global insulin delivery devices market to be valued at $13.8 billion by 2019, growing at a compound annual growth rate of 7 percent. The ...